Antiretroviral Pre-exposure prophylaxis for natural conception (PrEP-C) in serodiscordant female partners of HIV-infected men in sustained virologic suppression.
Latest Information Update: 20 Dec 2022
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- 19 Dec 2022 Status changed from recruiting to completed.
- 22 Feb 2018 New trial record